Pulike Biological Engineering (SHSE:603566) Margin of Safety % (DCF FCF Based): N/A (As of Jul. 07, 2026)


SHSE:603566 Pulike Biological Engineering Inc SHSE:603566
64 GF Score
Price ¥10.24
GF Value ¥14.18
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Pulike Biological Engineering Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Pulike Biological Engineering's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF FCF Based) is not calculated.

SHSE:603566 vs VRTX, REGN, ALNY: Margin of Safety % (DCF FCF Based) Comparison

For the Biotechnology subindustry, Pulike Biological Engineering's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pulike Biological Engineering Margin of Safety % (DCF FCF Based) vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pulike Biological Engineering's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where Pulike Biological Engineering's Margin of Safety % (DCF FCF Based) falls into.


SHSE:603566
64GF Score
Pulike Biological Engineering Inc SHSE:603566
Margin of Safety % (DCF FCF Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Pulike Biological Engineering (SHSE:603566) Overvalued in 2026?

Based on GuruFocus' analysis, Pulike Biological Engineering stock appears to be undervalued. The current stock price of ¥10.24 is trading 27.8% below its estimated GF Value™ of ¥14.18. GuruFocus considers Pulike Biological Engineering to be Modestly Undervalued.

Key valuation signals for SHSE:603566:

  • Margin of Safety % (DCF FCF Based): N/A
  • GF Value™: ¥14.18 vs. price of ¥10.24 (27.8% below fair value)
  • GF Score™: 64/100 with 5 warning signs

No single metric tells the full story. See the SHSE:603566 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Pulike Biological Engineering Business Description

Address 15th New governance, Henan Province, Luoyang, CHN, 471000
Pulike Biological Engineering Inc is engaged in the research and development and production and operation of veterinary drugs.
64GF Score

Get the complete analysis for SHSE:603566

Margin of Safety % (DCF FCF Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥10.24
Price
¥14.18
GF Value